Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IHH Healthcare BhdXKLS:5225 -0.50%89 3-Year EBITDA Growth Rate is 15.60% as of Jun. 2026, which is 21% above its 10-year median of 12.90. GuruFocus rates XKLS:5225 with a GF Score™ of 89/100 and a GF Value™ of RM8.33 (Fairly Valued). The stock has 5 warning signs investors should review. Among 523 Healthcare Providers & Services companies, IHH Healthcare Bhd ranks better than 59.85% on this metric.
During the past 12 months, IHH Healthcare Bhd's average EBITDA Per Share Growth Rate was 13.20% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 15.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 19.30% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 13.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of IHH Healthcare Bhd was 44.80% per year. The lowest was -2.00% per year. And the median was 12.90% per year.
IHH Healthcare Bhd (XKLS:5225) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
IHH Healthcare Bhd 3-Year EBITDA Growth Rate Related Terms
XKLS:5225 vs HCA, THC, EHC: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, IHH Healthcare Bhd's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IHH Healthcare Bhd 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, IHH Healthcare Bhd's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where IHH Healthcare Bhd's 3-Year EBITDA Growth Rate falls into.
IHH Healthcare Bhd 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 15.60% mean?
IHH Healthcare Bhd (XKLS:5225) has a 3-Year EBITDA Growth Rate of 15.60% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for IHH Healthcare Bhd and its competitors. This is 21% above median its historical median of 12.90. According to the industry distribution chart, IHH Healthcare Bhd ranks #210 out of 523 companies in the Healthcare Providers & Services industry, placing it in the top 40.2%.
Is IHH Healthcare Bhd's 3-Year EBITDA Growth Rate too high?
IHH Healthcare Bhd's current 3-Year EBITDA Growth Rate of 15.60% is 21% above median its 10-year median of 12.90. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 9.90. IHH Healthcare Bhd's value of 15.60% is 57.6% above this industry median. Based on the distribution chart, IHH Healthcare Bhd ranks #210 out of 523 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, IHH Healthcare Bhd has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IHH Healthcare Bhd's 3-Year EBITDA Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, IHH Healthcare Bhd ranks #210 out of 523 companies for 3-Year EBITDA Growth Rate. This puts IHH Healthcare Bhd in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 9.90. IHH Healthcare Bhd's value of 15.60% is 57.6% above this benchmark. While the company's 10-year median is 12.90 vs. the industry median of 9.90, IHH Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 9.90, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IHH Healthcare Bhd's current 3-Year EBITDA Growth Rate of 15.60% is 57.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for IHH Healthcare Bhd and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 9.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IHH Healthcare Bhd's current 3-Year EBITDA Growth Rate is 15.60%, which is 21% above median its own 10-year median of 12.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IHH Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, IHH Healthcare Bhd (XKLS:5225) is currently considered Fairly Valued. The stock's GF Value™ is RM8.33, compared to a current price of RM7.95 — trading 4.6% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 15.60%, which is 21% above median its 10-year median of 12.90 and 57.6% above the Healthcare Providers & Services industry median of 9.90. IHH Healthcare Bhd's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For IHH Healthcare Bhd (XKLS:5225), the current 3-Year EBITDA Growth Rate is 15.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IHH Healthcare Bhd (XKLS:5225) Overvalued in 2026?
Based on GuruFocus' analysis, IHH Healthcare Bhd stock appears to be undervalued.
The current stock price of RM7.95 is trading 4.6% below its estimated GF Value™ of RM8.33.
GuruFocus considers IHH Healthcare Bhd to be Fairly Valued.
Key valuation signals for XKLS:5225:
3-Year EBITDA Growth Rate: 15.60% (21% above median its 10-year median of 12.90)
GF Value™: RM8.33 vs. price of RM7.95 (4.6% below fair value)
Industry Position: 57.6% above the Healthcare Providers & Services median (#210 of 523)
No single metric tells the full story. See the XKLS:5225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IHH Healthcare Bhd is an investment holding company. Through its subsidiaries, it is a healthcare services provider that operates a network of hospitals. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The company's reportable segments include Healthcare services, Laboratories services, and Management fees. The majority of its revenue is generated from the Healthcare services segment, which relates to contracts with patients in which performance obligations are to provide healthcare services. Geographically, the company derives maximum revenue from Turkiye and Europe, followed by Singapore, Malaysia, India, Greater China, and Others.
89GF Score
Get the complete analysis for XKLS:5225
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5225 has been successfully added to your 
